PMID- 29662942 OWN - NLM STAT- MEDLINE DCOM- 20190111 LR - 20220331 IS - 2373-2822 (Electronic) IS - 2373-2822 (Linking) VI - 5 IP - 2 DP - 2018 Mar-Apr TI - Measuring and Validating the Levels of Brain-Derived Neurotrophic Factor in Human Serum. LID - 10.1523/ENEURO.0419-17.2018 [doi] LID - ENEURO.0419-17.2018 AB - Brain-derived neurotrophic factor (BDNF) secreted by neurons is a significant component of synaptic plasticity. In humans, it is also present in blood platelets where it accumulates following its biosynthesis in megakaryocytes. BDNF levels are thus readily detectable in human serum and it has been abundantly speculated that they may somehow serve as an indicator of brain function. However, there is a great deal of uncertainty with regard to the range of BDNF levels that can be considered normal, how stable these values are over time and even whether BDNF levels can be reliably measured in serum. Using monoclonal antibodies and a sandwich ELISA, this study reports on BDNF levels in the serum of 259 volunteers with a mean value of 32.69 +/- 8.33 ng/ml (SD). The mean value for the same cohort after 12 months was not significantly different (N = 226, 32.97 +/- 8.36 ng/ml SD, p = 0.19). Power analysis of these values indicates that relatively large cohorts are necessary to identify significant differences, requiring a group size of 60 to detect a 20% change. The levels determined by ELISA could be validated by Western blot analyses using a BDNF monoclonal antibody. While no association was observed with gender, a weak, positive correlation was found with age. The overall conclusions are that BDNF levels can be reliably measured in human serum, that these levels are quite stable over one year, and that comparisons between two populations may only be meaningful if cohorts of sufficient sizes are assembled. FAU - Naegelin, Yvonne AU - Naegelin Y AD - School of Biosciences, Cardiff University, Cardiff CF10 3AX, United Kingdom. AD - Department of Neurology, University Hospital Basel, Basel 4031, Switzerland. FAU - Dingsdale, Hayley AU - Dingsdale H AD - School of Biosciences, Cardiff University, Cardiff CF10 3AX, United Kingdom. FAU - Sauberli, Katharina AU - Sauberli K AD - School of Biosciences, Cardiff University, Cardiff CF10 3AX, United Kingdom. FAU - Schadelin, Sabine AU - Schadelin S AD - Clinical Trial Unit, Department of Clinical Research, University Hospital Basel, Basel 4031, Switzerland. FAU - Kappos, Ludwig AU - Kappos L AD - Department of Neurology, University Hospital Basel, Basel 4031, Switzerland. FAU - Barde, Yves-Alain AU - Barde YA AUID- ORCID: 0000-0002-7627-461X AD - School of Biosciences, Cardiff University, Cardiff CF10 3AX, United Kingdom. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20180322 PL - United States TA - eNeuro JT - eNeuro JID - 101647362 RN - 0 (Antibodies, Monoclonal) RN - 0 (Brain-Derived Neurotrophic Factor) RN - 7171WSG8A2 (BDNF protein, human) SB - IM MH - Adolescent MH - Adult MH - Aged MH - Antibodies, Monoclonal MH - Blood Chemical Analysis/*standards MH - Blotting, Western MH - Brain-Derived Neurotrophic Factor/*blood MH - Enzyme-Linked Immunosorbent Assay MH - Female MH - Follow-Up Studies MH - Humans MH - Male MH - Middle Aged MH - Reproducibility of Results MH - Young Adult PMC - PMC5898630 OTO - NOTNLM OT - BDNF OT - ELISA OT - Western blotting OT - antibodies OT - biomarkers OT - platelets EDAT- 2018/04/18 06:00 MHDA- 2019/01/12 06:00 PMCR- 2018/03/22 CRDT- 2018/04/18 06:00 PHST- 2017/12/05 00:00 [received] PHST- 2018/02/23 00:00 [revised] PHST- 2018/02/26 00:00 [accepted] PHST- 2018/04/18 06:00 [entrez] PHST- 2018/04/18 06:00 [pubmed] PHST- 2019/01/12 06:00 [medline] PHST- 2018/03/22 00:00 [pmc-release] AID - eN-NWR-0419-17 [pii] AID - 10.1523/ENEURO.0419-17.2018 [doi] PST - epublish SO - eNeuro. 2018 Mar 22;5(2):ENEURO.0419-17.2018. doi: 10.1523/ENEURO.0419-17.2018. eCollection 2018 Mar-Apr.